Loss of Parental Workforce in Paediatric Fractures

May 2, 2025 updated by: Ahmet Berkay Girgin, Ankara Etlik City Hospital

Childhood fractures are frequently encountered in orthopaedic practice. 40-64% of boys and 25-40% of girls have at least one fracture by the age of 16. Children, who are more fragile than adults, usually require additional care support during the treatment process. Labour force statistics have determined that one third of the loss of labour force occurs after musculoskeletal injuries.

When the literature is examined, there are many studies investigating loss of labour force after fractures. It was found that 20% of the patients never returned to work after distal radius fracture and the average loss of labour force was 9.2 weeks. In another study, while the return to work period was 60 days in minor hand injuries, it was reported that the return to work could increase to 360 days in major hand injuries. In another study, the average return to work time in patients aged >50 years with fragility fractures was found to be 20.5 days. The rate of return to work after traumatic spinal fracture was found to be only 38.1%.

In daily practice, the investigators observe that parents frequently do not go to work for child care after child fractures. However, there is no similar study investigating this loss of labour force after pediatric fractures in the literature. In this study, the investigators aimed to investigate the loss of parental labour force (LWL) in conservatively followed pediatric fractures

Study Overview

Study Type

Observational

Enrollment (Actual)

203

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yenimahalle
      • Ankara, Yenimahalle, Turkey, 06170
        • Ankara Etlik City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Parents of patients aged <18 years who were admitted to Ankara Etlik City Hospital Emergency Orthopaedics and Traumatology Outpatient Clinic and other Orthopaedics and Traumatology Outpatient Clinics and underwent plaster splinting due to any extremity fracture

Description

Inclusion Criteria:

  • patients <18 years of age who underwent plaster splinting for any extremity fracture

Exclusion Criteria:

  • Parents of patients aged >18 years
  • Parents of patients undergoing surgical treatment
  • Parents of patients whose initial diagnosis or follow-up was performed at an external centre
  • Patients with one parent not working (patients with one working parent will be excluded)
  • Parents of patients who did not want to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
pediatric fracture
all paediatric (<18 years) patients presenting with a fracture will be included in the study. parents of patients presenting with a fracture will be informed about the study and parents who are willing to participate in the study will be included. parents will be given a form indicating various workforce losses (including housework and social life) at the first application. this form will be received from the parents at the end of treatment. study data will be collected on this form.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Loss of Parental Workforce Questionnaire
Time Frame: from first presentation after fracture to the end of treatment (approximately 6 weeks in conservative cases, 3 months in surgical treatments)
A questionnaire called "Loss of Parental Workforce Questionnaire" will be used to evaluate the parental workforce loss. Also with this questionnaire the effect of treatment choice (conservative or surgical) to parental workforce loss will be assessed.
from first presentation after fracture to the end of treatment (approximately 6 weeks in conservative cases, 3 months in surgical treatments)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Children's Return to School Time
Time Frame: from first presentation after fracture to the end of treatment (approximately 6 weeks in conservative cases, 3 months in surgical treatments)
"Loss of Parental Workforce Questionnaire" will also be used to assess Children's Return to School Time.
from first presentation after fracture to the end of treatment (approximately 6 weeks in conservative cases, 3 months in surgical treatments)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2024

Primary Completion (Actual)

January 10, 2025

Study Completion (Actual)

April 30, 2025

Study Registration Dates

First Submitted

March 14, 2025

First Submitted That Met QC Criteria

March 21, 2025

First Posted (Actual)

March 24, 2025

Study Record Updates

Last Update Posted (Actual)

May 4, 2025

Last Update Submitted That Met QC Criteria

May 2, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AEŞH-BADEK-2024-1169

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Fractures

Subscribe